Skip to main content
. 2012 Jan 24;14(3):149–157. doi: 10.1111/j.1751-7176.2011.00588.x

Figure 3.

Figure 3

 Proportion of study participants achieving blood pressure (BP) targets at any time during the open‐label treatment period by final dosing regimen. AML indicates amlodipine besylate; HCTZ, hydrochlorothiazide; OM, olmesartan medoxomil; SeDBP, seated diastolic BP; SeSBP, seated systolic BP.